The largest database of trusted experimental protocols

Acipimox

Manufactured by Merck Group
Sourced in United States

Acipimox is a synthetic analogue of nicotinic acid (niacin) used as a lipid-lowering agent. It is primarily used to reduce elevated levels of triglycerides and cholesterol in the blood. Acipimox functions by inhibiting the release of free fatty acids from adipose tissue, which in turn reduces the production of very low-density lipoproteins (VLDL) in the liver.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using acipimox

1

Acipimox administration protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Acipimox (Sigma Aldrich, US) was i.p. administered at a dose of 100 mg/kg B.W. two times per day for five consecutive days. Control solution was sterile saline (0.9% NaCl).
+ Open protocol
+ Expand
2

Lipolysis Inhibitors Modulate Tumor Growth

Check if the same lab product or an alternative is used in the 5 most similar protocols
To study the role of lipolysis in vivo, mice were given two different lipolysis inhibitors: Acipimox or Atglistatin. Acipimox is a niacin derivate that suppresses cyclic adenosine monophosphate (cAMP), leading to a general inhibition of lipolysis [48 (link)]. Atglistatin is a selective and competitive inhibitor of ATGL, leaving other lipases unaffected [49 (link)]. Mice received either vehicle, Acipimox (0.5 g/L, Sigma-Aldrich, St. Louis, MO, USA) in drinking water or Atglistatin (0.1 μmol/g, Cayman Chemical Company, Ann Arbor, MI, USA) by oral gavage for 14 days after E0771 transplantation. In the Acipimox study, the drinking water was replaced two times per week and the water consumption of each cage was monitored every 24 h.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!